These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35234559)

  • 61. Experience of morphine therapy for refractory dyspnea as palliative care in advanced heart failure patients.
    Kawaguchi J; Hamatani Y; Hirayama A; Nishimura K; Nakai E; Nakamura E; Miyata M; Kawano Y; Takada Y; Anchi Y; Funabashi S; Kuroda K; Azechi M; Takahama H; Anzai T; Yasuda S; Kitaoka H; Izumi C
    J Cardiol; 2020 Jun; 75(6):682-688. PubMed ID: 32061472
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine.
    Nuñez S; Maisel A
    Am Heart J; 1998 Mar; 135(3):383-8. PubMed ID: 9580093
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Infusion therapy with milrinone in the home care setting for patients who have advanced heart failure.
    Boger JE; DeLuca SL; Watkins DF; Vershave KK; Thomley AM
    J Intraven Nurs; 1997; 20(3):148-54. PubMed ID: 9214927
    [TBL] [Abstract][Full Text] [Related]  

  • 65. IV milrinone for cardiac output increase and maintenance: comparison in nonhyperdynamic SIRS/sepsis and congestive heart failure.
    Heinz G; Geppert A; Delle Karth G; Reinelt P; Gschwandtner ME; Neunteufl T; Zauner C; Frossard M; Siostrzonek P
    Intensive Care Med; 1999 Jun; 25(6):620-4. PubMed ID: 10416916
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inotropes in Patients with Advanced Heart Failure: Not Only Palliative Care.
    Masarone D; Melillo E; Gravino R; Errigo V; Martucci ML; Caiazzo A; Petraio A; Pölzl G; Pacileo G
    Heart Fail Clin; 2021 Oct; 17(4):587-598. PubMed ID: 34511207
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure.
    Lanfear DE; Hasan R; Gupta RC; Williams C; Czerska B; Tita C; Bazari R; Sabbah HN
    J Transl Med; 2009 Jul; 7():67. PubMed ID: 19640280
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term intravenous inotropes in low-output terminal heart failure?
    von Scheidt W; Pauschinger M; Ertl G
    Clin Res Cardiol; 2016 Jun; 105(6):471-81. PubMed ID: 26879807
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.
    Simonton CA; Chatterjee K; Cody RJ; Kubo SH; Leonard D; Daly P; Rutman H
    J Am Coll Cardiol; 1985 Aug; 6(2):453-9. PubMed ID: 4019930
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
    Domínguez de Rozas JM; Guindo Soldevila J; Rodríguez Font E; Martínez Vílchez R
    Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.
    Martens P; Vercammen J; Ceyssens W; Jacobs L; Luwel E; Van Aerde H; Potargent P; Renaers M; Dupont M; Mullens W
    ESC Heart Fail; 2018 Aug; 5(4):562-569. PubMed ID: 29341466
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Educate, Nurture, Advise, Before Life Ends Comprehensive Heartcare for Patients and Caregivers (ENABLE CHF-PC): study protocol for a randomized controlled trial.
    Wells R; Stockdill ML; Dionne-Odom JN; Ejem D; Burgio KL; Durant RW; Engler S; Azuero A; Pamboukian SV; Tallaj J; Swetz KM; Kvale E; Tucker RO; Bakitas M
    Trials; 2018 Aug; 19(1):422. PubMed ID: 30081933
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of a transitional palliative care model on patients with end-stage heart failure: study protocol for a randomized controlled trial.
    Ng AY; Wong FK; Lee PH
    Trials; 2016 Mar; 17():173. PubMed ID: 27037096
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Is monitoring milrinone therapy useful in advanced heart failure?
    Vazir A; Leaver N; Lyster H; Alexanian A; Wilton P; Banner NR
    Int J Cardiol; 2011 Jun; 149(3):380-1. PubMed ID: 21450357
    [No Abstract]   [Full Text] [Related]  

  • 75. End-of-Life Decisions and Palliative Care in Advanced Heart Failure.
    Meyers DE; Goodlin SJ
    Can J Cardiol; 2016 Sep; 32(9):1148-56. PubMed ID: 27568873
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Use of intravenous inotropic therapy in the home.
    McCloskey WW
    Am J Health Syst Pharm; 1998 May; 55(9):930-5; quiz 953-4. PubMed ID: 9588252
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multidisciplinary Team-Based Palliative Care for Heart Failure and Food Intake at the End of Life.
    Shibata T; Mawatari K; Nakashima N; Shimozono K; Ushijima K; Yamaji Y; Tetsuka K; Murakami M; Okabe K; Yanai T; Nohara S; Takahashi J; Aoki H; Yasukawa H; Fukumoto Y
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371897
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study.
    López-Candales A; Vora T; Gibbons W; Carron C; Simmons P; Schwartz J
    J Med; 2002; 33(1-4):129-46. PubMed ID: 12939113
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of milrinone and epinephrine or dopamine on biventricular function and hemodynamics in right heart failure after pulmonary regurgitation.
    Hyldebrandt JA; Agger P; Sivén E; Wemmelund KB; Heiberg J; Frederiksen CA; Ravn HB
    Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H860-6. PubMed ID: 26092988
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Should heart failure be regarded as a terminal illness requiring palliative care? A study of heart failure patients', carers' and clinicians' understanding of heart failure prognosis and its management.
    Stocker R; Close H; Hancock H; Hungin APS
    BMJ Support Palliat Care; 2017 Dec; 7(4):464-469. PubMed ID: 28733461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.